The American Soybean Association’s (ASA) Biotech Working Group met in Washington, D.C., this week to discuss developments in the biotech trait approvals process and determine advocacy strategies on behalf of American soybean producers and biotech partner companies.
The group heard about biotech review improvements at the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) from Michael Gregoire, deputy administrator for APHIS’ Biotechnology Regulatory Services Program, followed by an update on Chinese biotech approvals from Mark Petry with the USDA’s Foreign Agricultural Service’s Office of Agreements and Scientific Affairs. The group then discussed the biotech approval processes of key soybean export markets.
Formed by ASA in 2007, the Biotech Working Group comprises farmer-leaders and staff from ASA, the United Soybean Board, the U.S. Soybean Export Council, and the major technology companies developing new biotech soybean events. The U.S. soybean industry has a robust pipeline of new biotech soybean events under development and the soy industry and U.S. farmers have much to gain from the commercialization of soybean biotech varieties that increase yield, improve food and feed nutrition, resist disease, offer competition and alternatives in the marketplace, and help in managing weed resistance issues.
For more information, contact ASA Executive Director of Member & Industry Relations Bill Schuermann at email@example.com.